PHASE III STUDY OF RADIATION THERAPY WITH OR WITHOUT CIS-PLATINUM IN PATIENTS WITH UNRESECTABLE SQUAMOUS OR UNDIFFERENTIATED CARCINOMA OF THE HEAD AND NECK: AN INTERGROUP TRIAL OF THE EASTERN COOPERATIVE ONCOLOGY GROUP (E2382)

PURPOSE: The Head and Neck Intergroup conducted a Phase III randomized trial to determine whether the addition weekly cisplatin to daily radiation therapy (RT) would improve survival in patients with unresectable squamous cell head-and-neck carcinoma. METHODS AND MATERIALS: Eligible patients were ra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Quon, Harry, Leong, Traci, Haselow, Robert, Leipzig, Bruce, Cooper, Jay, Forastiere, Arlene
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612971/
https://ncbi.nlm.nih.gov/pubmed/20888709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.06.038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares